Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 8:33 p.m.

    🔍 Veness Adam M (Executive)

    Company: Dianthus Therapeutics, Inc. /DE/ (DNTH)

    Report Date: 2026-08-13

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 15,000
    • Total shares sold: 15,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Common Stock at $18.17 per share (Direct)
      Date: 2026-08-13 | Code: M | equity_swap_involved: false | shares_owned_after: 15,000.00 | transaction_form_type: 4
    • Sold 15,000 shares of Stock Option (Right to Buy) at $18.17 per share (Derivative)
      Date: 2026-08-13 | Code: M | Expires: 2033-06-28 | equity_swap_involved: false | shares_owned_after: 73,240.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares of common stock underlying this stock option award vested as to 25% of the shares on June 20, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Search

News categories